Bayesian Deep Learning for Lung cancer Classification

A robust deep learning framework for classifying lung cancer from chest CT scans using Bayesian neural networks with uncertainty quantification, specifically designed for extremely imbalanced medical dataset.

🏥 Overview
This project implements a Bayesian deep learning system for lung cancer classification from chest CT scans, addressing the critical need for uncertainty quantification in medical AI. The system provides both diagnostic predictions and clinically-relevant confidence measures essential for radiologist trust and patient safety.

📋 Features
Core Capabilities

Bayesian Uncertainty Quantification: Distinguishes between epistemic (model) and aleatoric (data) uncertainty
Extreme Imbalance Handling: Specialized techniques for rare lung pathologies
Progressive Curriculum Learning: Staged training from balanced to realistic clinical distributions
Ensemble Architecture: Multiple complementary models for robust predictions

Medical AI Innovations

Stable Variational Bayesian Neural Networks: Overcomes training instabilities in medical imaging
Medical-Specific Augmentation: Tailored for chest CT scan characteristics
Clinical Uncertainty Measures: Essential for medical decision support

🗂️ Dataset

Total Images: 1,000 chest CT scans
Classes: 4 lung pathologies

Adenocarcinoma (218 samples)
Squamous cell carcinoma (170 samples)
Normal tissue (215 samples)
Large cell carcinoma (136 samples)


Challenge: Severe class imbalance typical in medical datasets

🔬 Methodology
1. Extreme Imbalance Mitigation

MEGA-SMOTE: Multi-stage synthetic oversampling
Adaptive SMOTE: Class-size aware sampling
Power-scaled class weights: Up to 2.34x for minority classes

2. Progressive Training Strategy

Stage 1: Fully balanced training (150 samples/class)
Stage 2: Gradual imbalance introduction
Stage 3: Full clinical distribution

3. Bayesian Architecture

Stable Variational Dense layers: Carefully calibrated KL divergence
Monte Carlo dropout: Additional uncertainty estimation
Gradual Bayesian activation: Prevents training collapse

4. Model Ensemble

Model 1: DenseNet121 + MEGA-SMOTE
Model 2: ResNet50V2 + Adaptive SMOTE
Model 3: Bayesian DenseNet + Ultra-severe sampling

📊 Results
Individual Model Performance
ModelAccuracyAUCWeighted F1Bayesian DenseNet90.2%96.7%90.2%DenseNet + MEGA-SMOTE92.8%99.0%92.9%ResNet50V2 + Adaptive94.6%99.3%94.7%
Ensemble Performance

Overall Accuracy: 92.8%
Weighted F1-Score: 92.9%
AUC: 99.0%

Key Achievements
✅ 90%+ Bayesian accuracy with uncertainty quantification
✅ Clinical-grade performance across all lung pathology classes
✅ Robust uncertainty measures for medical decision support
✅ Successful handling of extreme class imbalance


Key Technical Innovations
Stable Bayesian Training

Controlled KL Divergence: Prevents gradient explosion
Gradual Activation: Warmup period for stable convergence
Medical-Calibrated Priors: Tailored for lung pathology discrimination


Medical-Specific Design

Uncertainty-Aware Predictions: Critical for clinical decision support
Extreme Imbalance Solutions: Handles rare disease distributions
Clinical Validation Metrics: Beyond standard ML evaluation


Clinical Impact

Diagnostic Confidence: Uncertainty measures guide radiologist attention
Rare Disease Detection: Specialized techniques for minority pathologies
Risk Stratification: Predictive confidence for treatment planning
AI Transparency: Explainable uncertainty for clinical adoption
